Results for tag: "Certolizumab Pegol"

Certolizumab Pegol is a biologic drug used in the treatment of oncology. It is a humanized monoclonal antibody that binds to and inhibits tumor necrosis factor alpha (TNF-α), a cytokine involved in inflammation and cancer progression. Certolizumab Pegol is used to treat a variety of cancers, including colorectal, breast, and lung cancer. It is also used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis. Certolizumab Pegol is administered intravenously or subcutaneously, and is available in both brand-name and generic formulations. Certolizumab Pegol is a relatively new drug, and is still in the early stages of development. It is currently approved for use in the United States, Europe, and other countries. Clinical trials are ongoing to evaluate its efficacy in other types of cancer and autoimmune diseases. Companies in the Certolizumab Pegol market include UCB, Pfizer, Merck, and AbbVie. Show Less Read more